Avience Biomedicals (NSE:AVIENCE) Other Current Receivables: ₹3.3 Mil (As of Jan. 2026)


NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
5 GF Score
Price ₹414.95
View Full Analysis

What is Avience Biomedicals Other Current Receivables?

Avience Biomedicals NSE:AVIENCE 5 Other Current Receivables is ₹3.3 Mil as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100.

Avience Biomedicals's Other Current Receivables for the quarter that ended in Jan. 2026 was ₹3.3 Mil.

Avience Biomedicals's quarterly Other Current Receivables increased from Mar. 2024 (₹3.19 Mil) to Mar. 2025 (₹4.00 Mil) but then stayed the same from Mar. 2025 (₹4.00 Mil) to Jan. 2026 (₹3.30 Mil).

Avience Biomedicals's annual Other Current Receivables declined from Mar. 2023 (₹12.79 Mil) to Mar. 2024 (₹3.19 Mil) but then increased from Mar. 2024 (₹3.19 Mil) to Mar. 2025 (₹4.00 Mil).

Avience Biomedicals Other Current Receivables Related Terms

Avience Biomedicals Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Other Current Receivables Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Other Current Receivables
12.79 3.19 4.00

Avience Biomedicals Quarterly Data
Mar23 Mar24 Mar25 Jan26
Other Current Receivables 12.79 3.19 4.00 3.30
NSE:AVIENCE
5GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹3.3 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Other Current Receivables of ₹3.3 Mil as of Jan. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Other Current Receivables too high?
Avience Biomedicals' current Other Current Receivables is ₹3.3 Mil. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Other Current Receivables compare to ABT and SYK?
Avience Biomedicals' Other Current Receivables of ₹3.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Other Current Receivables is ₹3.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Other Current Receivables of ₹3.3 Mil. The current Other Current Receivables is ₹3.3 Mil. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Other Current Receivables is ₹3.3 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score

Get the complete analysis for NSE:AVIENCE

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹414.95
Price